Generic placeholder image

Current Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 0929-8673
ISSN (Online): 1875-533X

Review Article

Cancer Treatment with Liposomes Based Drugs and Genes Co-delivery Systems

Author(s): Chuanmin Zhang, Shubiao Zhang*, Defu Zhi and Jingnan Cui

Volume 25, Issue 28, 2018

Page: [3319 - 3332] Pages: 14

DOI: 10.2174/0929867325666180111093937

Price: $65

Abstract

There are several mechanisms by which cancer cells develop resistance to treatments, including increasing anti-apoptosis, increasing drug efflux, inducing angiogenesis, enhancing DNA repair and altering cell cycle checkpoints. The drugs are hard to reach curative effects due to these resistance mechanisms. It has been suggested that liposomes based co-delivery systems, which can deliver drugs and genes to the same tumor cells and exhibit synergistic anti-cancer effects, could be used to overcome the resistance of cancer cells. As the co-delivery systems could simultaneously block two or more pathways, this might promote the death of cancer cells by sensitizing cells to death stimuli. This article provides a brief review on the liposomes based co-delivery systems to overcome cancer resistance by the synergistic effects of drugs and genes. Particularly, the synergistic effects of combinatorial anticancer drugs and genes in various cancer models employing multifunctional liposomes based co-delivery systems have been discussed. This review also gives new insights into the challenges of liposomes based co-delivery systems in the field of cancer therapy, by which we hope to provide some suggestions on the development of liposomes based co-delivery systems.

Keywords: Co-delivery, cancer therapy, liposomes, drug, gene, synergistic effects.


Rights & Permissions Print Export Cite as
© 2023 Bentham Science Publishers | Privacy Policy